Items where authors include "Bruyère, O"

Article

Moon, RJ, Reginster, J-Y, Al-Daghri, NM et al. (26 more authors) (2023) Real-World Evidence: new opportunities for osteoporosis research. Recommendations from a Working Group from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Osteoporosis International, 34. pp. 1283-1299. ISSN 0937-941X

Veronese, N, Cooper, C, Bruyère, O et al. (23 more authors) (2022) Multimodal multidisciplinary management of patients with moderate to severe pain in knee osteoarthritis: a need to meet patient expectations. Drugs, 82 (13). pp. 1347-1355. ISSN 0012-6667

Hiligsmann, M, Dennison, E, Beaudart, C et al. (14 more authors) (2020) A Discrete-Choice Experiment to Assess Patients’ Preferences for Osteoarthritis Treatment: an ESCEO working group. Seminars in Arthritis and Rheumatism, 50 (5). pp. 859-866. ISSN 0049-0172

Fuggle, NR, Cooper, C, Oreffo, ROC et al. (24 more authors) (2020) Alternative and complementary therapies in osteoarthritis and cartilage repair. Aging Clinical and Experimental Research, 32 (4). pp. 547-560. ISSN 1594-0667

de Wit, M, Cooper, C, Tugwell, P et al. (25 more authors) (2019) Practical guidance for engaging patients in health research, treatment guidelines and regulatory processes: results of an expert group meeting organized by the World Health Organization (WHO) and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Aging Clinical and Experimental Research, 31 (7). pp. 905-915. ISSN 1594-0667

Reginster, J-Y, Bruyère, O, Conaghan, PG orcid.org/0000-0002-3478-5665 et al. (2 more authors) (2019) Importance of safety in the management of osteoarthritis and the need for updated meta-analyses and recommendations for reporting of harms. Drugs and Aging, 36 (Suppl 1). pp. 3-6. ISSN 1170-229X

Honvo, G, Bannuru, RR, Bruyère, O et al. (9 more authors) (2019) Recommendations for the reporting of harms in manuscripts on clinical trials assessing osteoarthritis drugs: A consensus statement from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Drugs and Aging, 36 (Suppl 1). pp. 145-159. ISSN 1170-229X

Fuggle, N, Curtis, E, Shaw, S et al. (12 more authors) (2019) Safety of opioids in osteoarthritis: Outcomes of a systematic review and meta-analysis. Drugs and Aging, 36 (Suppl 1). pp. 129-143. ISSN 1170-229X

Hiligsmann, M, Pinto, D, Dennison, E et al. (13 more authors) (2019) Patients’ preferences for osteoarthritis treatment: the value of stated-preference studies. Aging Clinical and Experimental Research, 31 (1). pp. 1-3. ISSN 1720-8319